Amicus Therapeutics Competitors and Similar CompaniesClear all
Amicus Therapeutics's competitors and similar companies include PhaseBio Pharmaceuticals and NIOX.
 Amicus Therapeutics Amicus Therapeutics is a biopharmaceutical company developing therapies for the treatment of rare and orphan diseases. |  PhaseBio Pharmaceuticals PhaseBio Pharmaceuticals is a biopharmaceutical company committed to developing new and improved drugs, with an initial focus on endocrine and metabolic disorders and cardiovascular disease. |  NIOX NIOX (formerly Circassia) is a specialty biopharmaceutical company focused on developing novel immunotherapies | |
Founding Date | Founding Date 2002 | Founding Date 2002 | Founding Date 2006 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations Philadelphia, US HQ Northbridge, AU Pointe Claire, CA Paris, FR München, DE Dublin, IE Milano, IT see more | Locations Malvern, US HQ | Locations Morrisville, US HQ Bad Homburg Vor Der Höhe, DE Uppsala, SE Morrisville, US |
Employees | Employees 58415% increase | Employees 22 | Employees 91 |
Valuation ($) | Valuation ($) 3.4 b | Valuation ($) N/A | Valuation ($) 340.9 m |
Financial | |||
Revenue (est.) | Revenue (est.) $634.2m (FY, 2025) | Revenue (est.) $10.8m (FY, 2021) | Revenue (est.) £48.7m (FY, 2025) |
Cost of goods | Cost of goods $72.9m (FY, 2025) | Cost of goods N/A | Cost of goods £11.1m (FY, 2025) |
Gross profit | Gross profit $561.3m (FY, 2025) | Gross profit N/A | Gross profit £38.2m (FY, 2025) |
Net income | Net income ($27.1m) (FY, 2025) | Net income ($131.1m) (FY, 2021) | Net income £7m (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised $ 88m | Total funding raised N/A | Total funding raised $ 122.8m |
For sources of this data, please see the company profile
View Company Profiles
PhaseBio Pharmaceuticals
HQ
Malvern, US
Employees
22
PhaseBio Pharmaceuticals is a biopharmaceutical company committed to developing new and improved drugs, with an initial focus on endocrine and metabolic disorders and cardiovascular disease.
View companyNIOX
HQ
Morrisville, US
Employees
91
NIOX (formerly Circassia) is a specialty biopharmaceutical company focused on developing novel immunotherapies
View company